Successful program to prevent aspergillus infections in children undergoing marrow transplantation: Use of nasal amphotericin

Bone Marrow Transplantation

Volumn 19, Issue 1, 1997, Pages 43-47

  Trigg, M E ^a,b   Morgan, D ^b   Burns, T L ^c   Kook, H ^a   Rumelhart, S L ^a   Holida, M D ^a   Giller, R H ^d  

^a Department of Pediatrics ^*  (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Amphotericin; Aspergillus; Bone marrow transplantation

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; BECLOMETASONE; HYDROCORTISONE;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; HUMAN; INFLAMMATION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL;

EID: 0031023767     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700618     Document Type: Article

References (20)

1. Meunier F, Leleux A, Snoeck R. Chemoprophylaxis of fungal infections. In: Holmberg K, Meyer R (eds). Diagnosis and Therapy of Systemic Fungal Infections. Raven Press: New York, 1989, pp 173-174.
2. O'Donnell MR, Schmidt GM, Tegtmeier BR et al. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 1994; 12: 827-834.
3. Trigg ME, Morgan DE, Burns TL et al. Aspergillosis prevention using intranasally administered amphotericin (INA). Proc Am Soc Clin Oncol 1992; 11: 400.
4. Trigg ME, Morgan D, Giller R et al. Intranasally administered amphotericin to prevent aspergillus in a pediatric bone marrow transplant setting. Exp Hematol 1994; 22: 689.
5. Meunier-Carpentier F, Snoeck R, Gerain J et al. Amphotericin B nasal spray as prophylaxis against aspergillus in patients with neutropenia. New Engl J Med 1984; 311: 1056.
6. Walsh TJ, Lee J, Lecciones J et al. Empiric therapy with amphotericin B in febrile granulocytopenic patients. Infect Dis 1991; 13: 496-503.
7. Morrison VA, Haake RJ, Weisdorf DJ. Non-candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med 1994; 96: 497-503.
8. Schmitt HJ, Bernard EM, Hauser M, Armstrong D. Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis. Antimicrob Agents Chemother 1988; 32: 1676-1679.
9. Niki Y, Bernard EM, Schmitt H-J et al. Pharmacokinetics of aerosol amphotericin B in rats. Antimicrob Agents Chemother 1990; 34: 29-32.
10. Denning DW, Donnelly JP, Hellreigel KP et al. Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad Hoc Working Group. Chemotherapy 1992; 38 (Suppl. 1): 43-49.
11. Morgan DE, Trigg ME, Giller RH, Peters C. Intranasal amphotericin B (IN-AMB) disposition in pediatric bone marrow transplant (BMT) patients. Proc Am Soc Clin Oncol 1992; 11: 399.
12. Tollemar J, Ringden O, Andersson S et al. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 1993; 12: 577-582.
13. Rousey SR, Russler S, Gottlieb M, Ash RC. Low-dose amphotericin B prophylaxis against invasive aspergillus infections in allogeneic marrow transplantation. Am J Med 1991; 91: 484-492.
14. Riley DK, Pavia AT, Beatty PG et al. The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am J Med 1994; 97: 509-514.
15. Christiansen KJ, Bernard EM, Gold JWM, Armstrong D. Distribution and activity of amphotericin B in humans. J Infect Dis 1985; 152: 1037-1043.
16. Benson JM, Nahata M. Pharmacokinetics of amphotericin B in children. Antimicrob Agents Chemother 1989; 33: 1989-1993.
17. Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989; 86: 791-800.
18. Lortholary O, Meyohas M-C, Dupont B et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on aspergillosis in AIDS. Am J Med 1992; 95: 177-187.
19. Lane HC, Laughon BE, Falloon J et al. Recent advances in the management of AIDS-related opportunistic infections. Ann Intern Med 1994; 120: 945-955.
20. Denning DW, Lee JY, Hostetler JS et al. NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994; 97: 135-144.